KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Pacira BioSciences (PCRX) over the last 15 years, with Q3 2025 value amounting to 0.29.

  • Pacira BioSciences' Debt Ratio rose 4320.96% to 0.29 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.29, marking a year-over-year increase of 4320.96%. This contributed to the annual value of 0.38 for FY2024, which is 37898.08% up from last year.
  • As of Q3 2025, Pacira BioSciences' Debt Ratio stood at 0.29, which was up 4320.96% from 0.2 recorded in Q2 2025.
  • In the past 5 years, Pacira BioSciences' Debt Ratio registered a high of 0.38 during Q4 2024, and its lowest value of 0.07 during Q2 2024.
  • Moreover, its 5-year median value for Debt Ratio was 0.17 (2022), whereas its average is 0.17.
  • Per our database at Business Quant, Pacira BioSciences' Debt Ratio plummeted by 6215.56% in 2023 and then skyrocketed by 37898.08% in 2024.
  • Pacira BioSciences' Debt Ratio (Quarter) stood at 0.33 in 2021, then crashed by 48.75% to 0.17 in 2022, then tumbled by 53.55% to 0.08 in 2023, then skyrocketed by 378.98% to 0.38 in 2024, then fell by 22.94% to 0.29 in 2025.
  • Its Debt Ratio stands at 0.29 for Q3 2025, versus 0.2 for Q2 2025 and 0.19 for Q1 2025.